Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Buy
53
ODYY Quote, Financials, Valuation and Earnings
Last price:
$0.0600
Seasonality move
:
-17.94%
Day range:
$0.0251 - $0.0740
52-week range:
$0.0050 - $0.1250
Dividend yield:
0%
P/E ratio:
0.41x
P/S ratio:
--
P/B ratio:
0.45x
Volume:
107.7K
Avg. volume:
70.8K
1-year change:
200%
Market cap:
$6M
Revenue:
--
EPS (TTM):
-$0.01
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Odyssey Health, Inc. has -- downside to fair value with a price target of -- per share.
ODYY vs. S&P 500
-
Over the past 5 trading days, Odyssey Health, Inc. has underperformed the S&P 500 by -16.82% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Odyssey Health, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Odyssey Health, Inc. revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Odyssey Health, Inc. reported revenues of --.
Earnings Growth
-
Odyssey Health, Inc. has grown year-over-year earnings for 3 quarters straight. In the most recent quarter Odyssey Health, Inc. reported earnings per share of -$0.00.
Enterprise value:
7.9M
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
0.43x
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
-20.73x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
0.43x
Gross Profit (TTM):
--
Return On Assets:
-624.99%
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-10-31 | 2024-10-31 | 2025-10-31 | 2024-10-31 | 2025-10-31 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -$3.6K | -$600 | -- | -- | -- | |
| Operating Income | -$4.3M | -$2.4M | -$744.5K | -$580.3K | -$303.2K | |
| EBITDA | -$4.3M | -$2.4M | -$744.5K | -$580.3K | -$303.2K | |
| Diluted EPS | -$0.05 | -$0.04 | -$0.01 | -$0.01 | -$0.00 | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $931.5K | $817.2K | $563.1K | $182.5K | $143.6K | |
| Total Assets | $931.8K | $867.7K | $612K | $341K | $143.6K | |
| Current Liabilities | $3.9M | $6.3M | $6.8M | $6.6M | $7.3M | |
| Total Liabilities | $3.9M | $6.3M | $6.8M | $6.6M | $7.3M | |
| Total Equity | -$3M | -$5.4M | -$6.2M | -$6.3M | -$7.2M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-10-31 | 2024-10-31 | 2025-10-31 | 2024-10-31 | 2025-10-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$1.2M | -$1.4M | -$382.9K | -$248.5K | -$284K | |
| Cash From Investing | -$2K | $1M | $69.8K | -- | -- | |
| Cash From Financing | $1.4M | $259.8K | $284.8K | $300K | $290.5K | |
| Free Cash Flow | -$1.3M | -$1.4M | -$382.9K | -$248.5K | -$284K | |
ODYY
Sector
Market Cap
$6M
--
Price % of 52-Week High
48%
--
Dividend Yield
0%
--
Shareholder Yield
-0.88%
--
1-Year Price Total Return
200%
--
Beta (5-Year)
-1.030
--
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$0.0647
200-day SMA
Buy
Level
$0.0408
Bollinger Bands (100)
Buy
Level
0.0388 - 0.0788
Chaikin Money Flow
Buy
Level
379K
20-day SMA
Sell
Level
$0.0659
Relative Strength Index (RSI14)
Buy
Level
50.6789
ADX Line
Sell
Level
38.5211
Williams %R
Neutral
Level
-29.6371
50-day SMA
Buy
Level
$0.0488
MACD (12, 26)
Buy
Level
0.0165
25-day Aroon Oscillator
Sell
Level
-24
On Balance Volume
Sell
Level
-539.2K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-2003.0065)
Sell
CA Score
(Annual)
Level (-105.9753)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (4)
Sell
Ohlson Score
Level (1075.4756)
--
Piotroski F Score
(Annual)
Level (--)
Buy
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Odyssey Health, Inc. is a medical device technology and asset acquisition company, which engages in the development and acquisition of medical-related products. It owns heart monitoring and screening, choking rescue devices, and neurosteroid drug compounds. The company was founded in March 2014 and is headquartered in Las Vegas, NV.
Stock Forecast FAQ
In the current month, ODYY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ODYY average analyst price target in the past 3 months is --.
-
Where Will Odyssey Health, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Odyssey Health, Inc. share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Odyssey Health, Inc.?
Analysts are divided on their view about Odyssey Health, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Odyssey Health, Inc. is a Sell and believe this share price will rise from its current level to --.
-
What Is Odyssey Health, Inc.'s Price Target?
The price target for Odyssey Health, Inc. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is ODYY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Odyssey Health, Inc. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of ODYY?
You can purchase shares of Odyssey Health, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Odyssey Health, Inc. shares.
-
What Is The Odyssey Health, Inc. Share Price Today?
Odyssey Health, Inc. was last trading at $0.0600 per share. This represents the most recent stock quote for Odyssey Health, Inc.. Yesterday, Odyssey Health, Inc. closed at $0.0600 per share.
-
How To Buy Odyssey Health, Inc. Stock Online?
In order to purchase Odyssey Health, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get ODYY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ODYY
Sector
P/E ratio
0.41x
--
PEG ratio
--
--
P/B ratio
0.45x
--
Price / LTM sales
--
--
Growth Metrics
ODYY
Sector
Revenue growth
--
--
Earnings growth
52.58%
--
Revenue (5-year growth)
--
--
Earnings forecast
--
--
Profitability
ODYY
Sector
Profitability FY 2025
--
--
Return on invested capital
--
--
Return on assets
-624.99%
--
Return on equity
--
--
Earnings Date
Last Earnings Date
Feb
8
Next Earnings Date
Feb
8
Estimated Next Earnings Date
May
10
Balance Sheet
ODYY
Sector
Total cash
$25.6K
--
Short term investments
--
--
Total assets
$49.7K
--
Long term debt
--
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
53
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 30x
Alerts
Sell
40
BILL alert for Feb 7
Bill Holdings, Inc. [BILL] is up 37.11% over the past day.
Buy
75
PRLB alert for Feb 7
Proto Labs, Inc. [PRLB] is up 28.33% over the past day.
Sell
30
MSTR alert for Feb 7
Strategy, Inc. [MSTR] is up 26.08% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
